Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$29,576,746
+$6,968,800 QoQ
Shares Held
24,659
+0.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#725
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOCQUEVILLE ASSET MANAGEMENT L.P. holds $293,455,653 across 12 Drug Manufacturers - General names. LLY ranks #4 (10.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
336,097 | $84,575,449 | |
| 2 | JNJ |
Johnson & Johnson
|
258,233 | $65,583,435 | |
| 3 | MRK |
Merck & Co., Inc.
|
447,832 | $57,546,412 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
24,659 | $29,576,746 | |
| 5 | NVS |
Novartis AG
|
79,360 | $12,437,299 | |
| 6 | PFE |
Pfizer Inc
|
465,004 | $11,197,296 | |
| 7 | SNY |
Sanofi
|
195,567 | $8,342,888 | |
| 8 | AMGN |
Amgen Inc
|
21,433 | $7,761,317 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,576,746 | 24,659 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $22,607,946 | 24,580 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $26,785,326 | 24,924 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $18,615,674 | 24,398 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $18,711,838 | 24,004 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $20,961,595 | 25,380 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $19,797,940 | 25,645 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $17,761,325 | 20,048 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $18,264,230 | 20,173 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $16,029,865 | 20,605 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $9,555,224 | 16,392 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $4,277,166 | 7,963 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,815,152 | 8,135 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,754,915 | 8,022 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,833,796 | 7,746 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,487,208 | 7,692 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,496,246 | 7,699 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,952,761 | 10,311 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,875,726 | 10,411 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,403,151 | 10,401 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,385,630 | 10,394 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,084,350 | 11,157 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,186,984 | 12,953 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,956,972 | 13,221 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,234,818 | 13,612 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $2,176,794 | 15,692 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||